Amphastar Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03209R1032
USD
26.60
0.1 (0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
731.97
644.39
498.99
437.77
349.85
322.36
294.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
731.97
644.39
498.99
437.77
349.85
322.36
294.67
Raw Material Cost
370.60
300.43
260.19
249.27
216.55
199.17
193.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.34
27.16
1.85
0.89
0.37
0.12
0.24
Selling and Distribution Expenses
94.52
80.39
66.59
68.56
65.02
62.97
57.86
Other Expenses
3.11
3.67
6.29
4.88
5.67
6.01
5.22
Total Expenditure (Excl Depreciation)
526.55
444.71
391.49
367.53
338.65
322.40
303.29
Operating Profit (PBDIT) excl Other Income
205.39999999999998
199.7
107.5
70.19999999999999
11.200000000000001
0
-8.6
Other Income
9.69
-4.37
5.46
-1.17
6.86
0.49
-1.06
Operating Profit (PBDIT)
272.31
237.09
141.70
95.82
43.24
21.57
6.83
Interest
30.34
27.16
1.85
0.89
0.37
0.12
0.24
Exceptional Items
5.00
3.20
4.93
15.96
-13.04
59.90
0.00
Gross Profit (PBDT)
361.37
343.97
238.80
188.50
133.29
123.19
101.67
Depreciation
57.20
41.78
28.74
26.75
25.18
21.12
16.52
Profit Before Tax
189.76
171.36
116.04
84.14
4.64
60.23
-9.93
Tax
29.67
31.83
23.48
20.63
3.54
13.72
-3.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
159.52
137.54
91.39
62.12
1.40
48.94
-5.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
159.52
137.54
91.39
62.12
1.40
48.94
-5.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
1.19
-0.31
-2.43
-0.92
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
159.52
137.54
91.39
63.30
1.10
46.51
-6.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
732.30
639.42
528.66
445.52
402.31
381.37
332.44
Earnings per share (EPS)
3.06
2.6
1.74
1.25
0.03
0.98
-0.12
Diluted Earnings per share
3.06
2.6
1.74
1.25
0.03
0.98
-0.12
Operating Profit Margin (Excl OI)
28.06%
30.99%
21.54%
16.04%
3.2%
-0.01%
-2.93%
Gross Profit Margin
33.74%
33.08%
29.01%
25.33%
8.52%
25.24%
2.24%
PAT Margin
21.79%
21.34%
18.31%
14.19%
0.4%
15.18%
-1.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 13.59% vs 29.14% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 16.00% vs 50.44% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 8.74% vs 77.31% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 11.40% vs 1,411.11% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Amphastar Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
731.97
560.23
171.74
30.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
731.97
560.23
171.74
30.66%
Raw Material Cost
370.60
106.77
263.83
247.10%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
30.34
63.04
-32.70
-51.87%
Selling and Distribution Expenses
94.52
321.61
-227.09
-70.61%
Other Expenses
3.11
60.48
-57.37
-94.86%
Total Expenditure (Excl Depreciation)
526.55
1,096.20
-569.65
-51.97%
Operating Profit (PBDIT) excl Other Income
205.42
-535.97
741.39
138.33%
Other Income
9.69
32.54
-22.85
-70.22%
Operating Profit (PBDIT)
272.31
-467.89
740.20
158.20%
Interest
30.34
63.04
-32.70
-51.87%
Exceptional Items
5.00
-1.11
6.11
550.45%
Gross Profit (PBDT)
361.37
453.46
-92.09
-20.31%
Depreciation
57.20
35.54
21.66
60.95%
Profit Before Tax
189.76
-567.59
757.35
133.43%
Tax
29.67
1.60
28.07
1,754.38%
Provisions and contingencies
0
0
0.00
Profit After Tax
159.52
-569.18
728.70
128.03%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
159.52
-569.18
728.70
128.03%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
159.52
-569.18
728.70
128.03%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
732.30
255.30
477.00
186.84%
Earnings per share (EPS)
3.06
-6.29
9.35
148.65%
Diluted Earnings per share
3.06
-6.29
9.35
148.65%
Operating Profit Margin (Excl OI)
28.06%
-95.67%
0.00
123.73%
Gross Profit Margin
33.74%
-94.97%
0.00
128.71%
PAT Margin
21.79%
-101.60%
0.00
123.39%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 73.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 13.59% vs 29.14% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 15.95 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.00% vs 50.44% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.74% vs 77.31% in Dec 2023

Annual - Interest
Interest 3.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.40% vs 1,411.11% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.06%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023